• Теги
    • избранные теги
    • Компании1358
      • Показать ещё
      Разное274
      • Показать ещё
      Страны / Регионы325
      • Показать ещё
      Международные организации29
      • Показать ещё
      Показатели17
      • Показать ещё
      Формат9
      Издания12
      Люди16
      • Показать ещё
      Сферы1
19 мая, 14:47

Why Is Johnson & Johnson (JNJ) Up 4.4% Since the Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

19 мая, 14:43

Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More

This week, industry bellwether J&J (JNJ) provided a look at its pharma pipeline while Shire was up on HAE data.

18 мая, 17:23

J&J (JNJ) Plans to Seek Approval for 10 New Drugs by 2021

Johnson & Johnson, Inc. (JNJ) discussed its future plans and showcased a strong pipeline of transformational medicines at a meeting held yesterday with industry analysts.

27 апреля, 18:29

United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss

United Therapeutics Corporation (UTHR) reported adjusted earnings of $3.89 per share (including stock-based compensation benefit) for the first quarter of 2017

26 апреля, 16:30

The Zacks Analyst Blog Highlights: Johnson & Johnson, Schlumberger, Honeywell, Alphabet and SunTrust Banks

The Zacks Analyst Blog Highlights: Johnson & Johnson, Schlumberger, Honeywell, Alphabet and SunTrust Banks

19 апреля, 17:55

Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

18 апреля, 20:55

After Johnson & Johnson Earnings, Buy These Pharma Stocks

Shares of Johnson & Johnson (JNJ) slid nearly 3.5% in morning trading Tuesday after the pharma giant's first-quarter earnings results were met with mixed reactions from investors. As the sell-off continues, investors focused on large-cap pharma companies may want to move their money into stronger options this earnings season.

18 апреля, 17:20

J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down

Johnson & Johnson (JNJ) reported mixed first quarter results, with earnings beating expectations while sales missing the same.

18 апреля, 15:35

Did Pharma & Biotech M&As Pick Pace in Q1?

Post-election, hopes surged that there would be an increase in M&A activity in the pharma and biotech sector in 2017.

12 апреля, 14:36

Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback

Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.

10 апреля, 16:30

The Zacks Analyst Blog Highlights: Johnson & Johnson, Verizon, Visa, General Dynamics and Abbott

The Zacks Analyst Blog Highlights: Johnson & Johnson, Verizon, Visa, General Dynamics and Abbott

Выбор редакции
04 апреля, 14:02

United Therapeutics Tanks, Remodulin Pump Launch Delayed

United Therapeutics Corporation (UTHR) shares plunged around 9% on Monday after the company announced that regulatory issues will delay the planned U.S. launch of RemoSynch - an implantable pump for delivering Remodulin

Выбор редакции
28 марта, 09:43

Why Is United Therapeutics (UTHR) Down 5.6% Since the Last Earnings Report?

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

24 марта, 14:47

Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved

This week's highlights include rumors regarding Sanofi (SNY) acquiring Flexion, accelerated FDA approval for a Pfizer/Merck KGaA drug and drug pricing.

02 марта, 17:30

Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis

Zacks Industry Outlook Highlights: GlaxoSmithKline, Celgene and Exelixis

01 марта, 23:19

M&As, Pipeline Catalysts to Drive Pharma Sector

M&As, Pipeline Catalysts to Drive Pharma Sector

28 февраля, 17:30

Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly

Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen’s and Lilly

28 февраля, 00:41

Pharma Industry Outlook - February/March 2017

Pharma Industry Outlook - February/March 2017